XML 35 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Feb. 01, 2020
Feb. 02, 2019
Feb. 03, 2018
Income Statement [Abstract]      
Sales $ 474,038 $ 473,756 $ 467,976
Cost of goods sold including occupancy costs 269,837 262,467 257,619
Gross profit 204,201 211,289 210,357
Expenses:      
Selling, general and administrative 180,663 183,868 193,230
Exit costs associated with London operations 1,737    
CEO transition costs 743 2,404  
Corporate restructuring charge   1,904  
Impairment of assets 889 4,579 4,095
Depreciation and amortization 24,563 28,653 31,073
Total expenses 208,595 221,408 228,398
Operating loss (4,394) (10,119) (18,041)
Interest expense, net (3,297) (3,462) (3,357)
Loss before provision (benefit) for income taxes (7,691) (13,581) (21,398)
Provision (benefit) for income taxes 105 (50) (2,572)
Net loss $ (7,796) $ (13,531) $ (18,826)
Net loss per share - basic and diluted $ (0.16) $ (0.28) $ (0.39)
Weighted-average number of common shares outstanding:      
Basic and diluted 49,992 49,163 48,888